Fjarde Ap Fonden Laboratory Corp Of America Holdings Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$209.01 - $232.56 $668,832 - $744,192	-3,200 Reduced 29.07%	7,807 $1.71 Million
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $1.27 Million - $1.45 Million	6,400 Added 138.92%	11,007 $2.5 Million
Q3 2023 Oct 23, 2023	SELL	$201.05 - $221.7 $442,310 - $487,740	-2,200 Reduced 32.32%	4,607 $926,000
Q2 2023 Aug 02, 2023	SELL	$211.93 - $241.33 $3.14 Million - $3.58 Million	-14,820 Reduced 68.53%	6,807 $1.64 Million
Q1 2023 May 15, 2023	BUY	$213.32 - $257.83 $327,872 - $396,284	1,537 Added 7.65%	21,627 $4.96 Million
Q4 2022 Feb 14, 2023	SELL	$203.72 - $248.97 $1.55 Million - $1.9 Million	-7,617 Reduced 27.49%	20,090 $4.73 Million
Q2 2022 Aug 11, 2022	SELL	$213.86 - $277.87 $470,492 - $611,314	-2,200 Reduced 7.36%	27,707 $6.49 Million
Q1 2022 May 13, 2022	SELL	$259.82 - $298.18 $129,910 - $149,090	-500 Reduced 1.64%	29,907 $7.89 Million
Q4 2021 Feb 15, 2022	BUY	$271.6 - $314.21 $369,647 - $427,639	1,361 Added 4.69%	30,407 $9.55 Million
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $549,640 - $616,680	-2,000 Reduced 6.44%	29,046 $8.18 Million
Q2 2021 Aug 12, 2021	BUY	$251.87 - $278.14 $125,935 - $139,070	500 Added 1.64%	31,046 $8.56 Million
Q1 2021 May 17, 2021	BUY	$204.88 - $255.03 $450,736 - $561,066	2,200 Added 7.76%	30,546 $7.79 Million
Q4 2020 Feb 12, 2021	SELL	$186.91 - $214.42 $18,691 - $21,442	-100 Reduced 0.35%	28,346 $5.77 Million
Q3 2020 Nov 13, 2020	BUY	$167.03 - $201.3 $267,248 - $322,080	1,600 Added 5.96%	28,446 $5.36 Million
Q2 2020 Aug 13, 2020	SELL	$113.31 - $182.44 $543,208 - $874,617	-4,794 Reduced 15.15%	26,846 $4.46 Million
Q1 2020 May 11, 2020	BUY	$104.32 - $195.28 $41,728 - $78,112	400 Added 1.28%	31,640 $4 Million
Q4 2019 Feb 10, 2020	BUY	$163.48 - $173.61 $2.34 Million - $2.48 Million	14,300 Added 84.42%	31,240 $5.29 Million
Q3 2019 Oct 31, 2019	SELL	$159.77 - $178.1 $2.11 Million - $2.35 Million	-13,205 Reduced 43.8%	16,940 $2.85 Million
Q2 2019 Jul 17, 2019	SELL	$144.16 - $172.9 $158,576 - $190,190	-1,100 Reduced 3.52%	30,145 $5.21 Million
Q1 2019 Apr 29, 2019	BUY	$123.7 - $156.3 $601,058 - $759,461	4,859 Added 18.42%	31,245 $4.78 Million
Q4 2018 Jan 31, 2019	SELL	$120.82 - $174.09 $447,034 - $644,133	-3,700 Reduced 12.3%	26,386 $3.33 Million
Q3 2018 Nov 09, 2018	SELL	$167.67 - $188.27 $19,282 - $21,651	-115 Reduced 0.38%	30,086 $5.23 Million
Q2 2018 Jul 12, 2018	BUY	$160.33 - $189.41 $249,313 - $294,532	1,555 Added 5.43%	30,201 $5.42 Million
Q1 2018 May 07, 2018	SELL	$161.53 - $178.11 $126,801 - $139,816	-785 Reduced 2.67%	28,646 $4.63 Million
Q4 2017 Feb 12, 2018	BUY	$147.99 - $163.95 $590,776 - $654,488	3,992 Added 15.69%	29,431 $4.7 Million
Q3 2017 Nov 07, 2017	BUY	$149.47 - $160.56 $77,425 - $83,170	518 Added 2.08%	25,439 $3.84 Million
Q2 2017 Aug 08, 2017	BUY	N/A	24,921	24,921 $3.84 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account